These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19623468)

  • 1. Migraine in the triptan era: progresses achieved, lessons learned and future developments.
    Bigal ME; Krymchantowski AV; Ho T
    Arq Neuropsiquiatr; 2009 Jun; 67(2B):559-69. PubMed ID: 19623468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptans and migraine: advances in use, administration, formulation, and development.
    Macone AE; Perloff MD
    Expert Opin Pharmacother; 2017 Mar; 18(4):387-397. PubMed ID: 28129702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science.
    Bigal ME; Ferrari M; Silberstein SD; Lipton RB; Goadsby PJ
    Headache; 2009 Feb; 49 Suppl 1():S21-33. PubMed ID: 19161562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Almotriptan for the acute treatment of adolescent migraine.
    Lewis DW
    Expert Opin Pharmacother; 2010 Oct; 11(14):2431-6. PubMed ID: 20828268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is selective 5-HT
    Rubio-Beltrán E; Labastida-Ramírez A; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2018 Jun; 186():88-97. PubMed ID: 29352859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptans for Acute Migraine Headache: Current Experience With Triptan Use and Prescription Habits in a Tertiary Care Headache Outpatient Clinic: An Observational Study.
    Fischer M; Frank F; Wille G; Klien S; Lackner P; Broessner G
    Headache; 2016 Jun; 56(6):952-60. PubMed ID: 27091593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual triptan selection in migraine attack therapy.
    Belvís R; Pagonabarraga J; Kulisevsky J
    Recent Pat CNS Drug Discov; 2009 Jan; 4(1):70-81. PubMed ID: 19149716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of current and future drugs for the acute treatment of migraine: a review and an update.
    Tfelt-Hansen P
    Curr Clin Pharmacol; 2012 Feb; 7(1):66-72. PubMed ID: 22299771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.
    Pascual J; Mateos V; Roig C; Sanchez-Del-Rio M; Jiménez D
    Headache; 2007 Sep; 47(8):1152-68. PubMed ID: 17883520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin receptor ligands: treatments of acute migraine and cluster headache.
    Goadsby PJ
    Handb Exp Pharmacol; 2007; (177):129-43. PubMed ID: 17087122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs.
    Ramírez Rosas MB; Labruijere S; Villalón CM; Maassen Vandenbrink A
    Expert Opin Pharmacother; 2013 Aug; 14(12):1599-610. PubMed ID: 23815106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Triptans in migraine--here and now (15 years after they were implemented in therapy)].
    Prusiński A; Rozniecki JJ
    Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S68-77. PubMed ID: 16419574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naratriptan: an alternative for migraine.
    Dulli DA
    Ann Pharmacother; 1999 Jun; 33(6):704-11. PubMed ID: 10410185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapies in development for the treatment of migraine.
    Mucke H
    Expert Opin Investig Drugs; 2002 Dec; 11(12):1813-20. PubMed ID: 12457440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.
    Allais G; Rolando S; De Lorenzo C; Benedetto C
    Expert Rev Neurother; 2014 Aug; 14(8):867-77. PubMed ID: 25056381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
    Ferrari MD; Goadsby PJ; Roon KI; Lipton RB
    Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans.
    Géraud G; Keywood C; Senard JM
    Headache; 2003 Apr; 43(4):376-88. PubMed ID: 12656709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic evaluation of frovatriptan.
    Negro A; Lionetto L; Casolla B; Lala N; Simmaco M; Martelletti P
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Triptans and calcitonin gene-related peptide (CGRP) receptor antagonists].
    Negoro K
    Rinsho Shinkeigaku; 2012; 52(11):971-2. PubMed ID: 23196486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Triptans--pivotal event in migraine treatment].
    Lusić I; Bilić I
    Acta Med Croatica; 2008 May; 62(2):173-8. PubMed ID: 18710081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.